Candriam SCA’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-227,500
| Closed | -$2.67M | – | 836 |
|
|
2019
Q2 | $2.67M | Hold |
227,500
| – | – | 0.03% | 451 |
|
|
2019
Q1 | $3.11M | Hold |
227,500
| – | – | 0.04% | 410 |
|
|
2018
Q4 | $2.33M | Hold |
227,500
| – | – | 0.04% | 425 |
|
|
2018
Q3 | $3.79M | Buy |
227,500
+10,000
| +5% | +$167K | 0.05% | 377 |
|
|
2018
Q2 | $3.44M | Buy |
217,500
+41,500
| +24% | +$656K | 0.05% | 369 |
|
|
2018
Q1 | $2.24M | Buy |
176,000
+75,000
| +74% | +$952K | 0.04% | 457 |
|
|
2017
Q4 | $1.16M | Sell |
101,000
-16,000
| -14% | -$183K | 0.02% | 566 |
|
|
2017
Q3 | $1.43M | Hold |
117,000
| – | – | 0.03% | 510 |
|
|
2017
Q2 | $1.34M | Buy |
117,000
+8,000
| +7% | +$91.6K | 0.03% | 534 |
|
|
2017
Q1 | $2.27M | Buy |
109,000
+69,000
| +173% | +$1.44M | 0.04% | 419 |
|
|
2016
Q4 | $832K | Hold |
40,000
| – | – | 0.02% | 544 |
|
|
2016
Q3 | $1.31M | Buy |
+40,000
| New | +$1.31M | 0.03% | 444 |
|
|
2015
Q3 | – | Sell |
-40,000
| Closed | -$2.12M | – | 657 |
|
|
2015
Q2 | $2.12M | Buy |
+40,000
| New | +$2.12M | 0.04% | 356 |
|